Joint Order, to Recall from the Governor's Desk to the Senate L.D. 1018, An Act to Protect Health Care for Rural and Underserved Areas by Prohibiting Discrimination by Participants in a Federal Drug Discount Program
Summary
SP0798 is a joint order directing that L.D. 1018, titled "An Act to Protect Health Care for Rural and Underserved Areas by Prohibiting Discrimination by Participants in a Federal Drug Discount Program," and its accompanying papers be recalled from the Governor's desk to the Senate. In practical terms, this is a procedural measure rather than a substantive policy change: it pulls the underlying bill back from the executive branch so the Senate can further consider it.
Because the text of SP0798 itself only addresses the recall of the bill, it does not create new health care rules or amend statutes directly. Its effect is to reopen legislative consideration of L.D. 1018, which appears aimed at protecting access to health care in rural and underserved areas by addressing discrimination involving participants in a federal drug discount program, likely the federal 340B program. Any legal impact would come from the underlying bill, not from this joint order alone.
Impact
SP0798 would affect legislative procedure by returning L.D. 1018 from the Governor's desk to the Senate for further action. It does not itself amend Maine statutes or regulate health care providers, pharmacies, or drug discount program participants; instead, it preserves the Legislature's ability to revisit the underlying proposal concerning access to discounted prescription drugs and rural health care.
Sentiment
No committee transcript or vote record is provided for SP0798, so there is no direct evidence of debate, support, or opposition on this joint order itself. The caption of the underlying bill suggests a policy goal of protecting rural and underserved health care access, which may indicate a generally pro-access framing, but the available record does not show how legislators felt about the recall motion specifically.
Contention
The only identifiable point of contention from the available materials is procedural: whether the Senate should recall L.D. 1018 from the Governor's desk for additional consideration. Because no discussion transcripts or votes are included, there is no record here of substantive disagreements over the underlying policy, such as the scope of protections for participants in the federal drug discount program, impacts on pharmacies or drug manufacturers, or effects on rural health care access.
Protecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program.
Relates to establishing the "340B prescription drug anti-discrimination act"; prohibits pharmaceutical manufacturers and pharmacy benefit managers from discriminating against covered entities and New York state pharmacies based on participation in the drug discount program authorized by section 340B of the federal public health service act.
Relates to establishing the "340B prescription drug anti-discrimination act"; prohibits pharmaceutical manufacturers and pharmacy benefit managers from discriminating against covered entities and New York state pharmacies based on participation in the drug discount program authorized by section 340B of the federal public health service act.